Objective: Primary anterior cerebral artery (ACA) occlusion is a rare condition and sometimes leads to significant neurological deficits. We herein report on the efficacy of mechanical thrombectomy (MT) in treating the distal ACA occlusion in a clinical setting. Case Presentation: A 76-year-old woman presented with a sudden onset of right hemiparesis. Computed tomographic angiography and perfusion imaging and subsequent analysis with RAPID software revealed acute left ACA occlusion with salvageable penumbra. The patient obtained a score of 11 on the National Institutes of Health Stroke Scale. MT was performed for occlusion of the left ACA (A4), and successful reperfusion (Thrombolysis in Cerebral Infarction score of 3) was achieved on the first attempt using a stent retriever. The patient’s recovery progressed well, and she was discharged 13 days after admission with a modified Rankin Scale score of 1. Conclusion: This case report demonstrates the clinical efficacy, safety, and favorable clinical outcome of treating a primary distal ACA occlusion with MT.

Randomized clinical trials have demonstrated mechanical thrombectomy (MT) to be the gold-standard treatment for large vessel occlusions. These studies included proximal occlusions involving the distal internal carotid artery and proximal middle cerebral artery (MCA). More distal occlusions of arteries may sometimes lead to significant neurological deficits [1-3]. Several case series provide evidence for the efficacy and high reperfusion rates of MT for distal occlusions of vessels [1, 2, 4-7]. However, the literature features a dearth of reports on the use of MT to treat anterior cerebral artery (ACA) occlusions. There is no consensus as to what cases of ACA occlusions should be treated with MT. We herein present a case of distal ACA occlusion that was successfully reperfused with MT by using a stent retriever.

A 76-year-old female presented with a sudden onset of right hemiparesis and was referred to our hospital 20 min after onset. She had no history of atrial fibrillation. Neurologic examinations performed at admission revealed right hemiparesis, hemisensory disturbance, right facial palsy, and a score of 11 on the National Institutes of Health Stroke Scale (NIHSS). At admission, computed tomographic angiography and perfusion imaging were performed, and subsequent analysis with RAPID software revealed acute left ACA occlusion with salvageable penumbra (Fig. 1).

Fig. 1.

The computed tomography perfusion mismatch map compares the ischemic core lesion, defined by the reduction of cerebral blood flow to <30% of the corresponding contralateral territory in pink (left), to regions with significant hypoperfusion, defined by a >6-s delay of the maximum of the tissue residue function (Tmax >6 s) in green (right). The difference and ratio between these volumes (mismatch volume, mismatch ratio, respectively) were automatically calculated. This computed tomography perfusion map demonstrates salvageable penumbra in the left anterior cerebral artery territory and no ischemic core.

Fig. 1.

The computed tomography perfusion mismatch map compares the ischemic core lesion, defined by the reduction of cerebral blood flow to <30% of the corresponding contralateral territory in pink (left), to regions with significant hypoperfusion, defined by a >6-s delay of the maximum of the tissue residue function (Tmax >6 s) in green (right). The difference and ratio between these volumes (mismatch volume, mismatch ratio, respectively) were automatically calculated. This computed tomography perfusion map demonstrates salvageable penumbra in the left anterior cerebral artery territory and no ischemic core.

Close modal

The patient was treated with intravenous recombinant tissue plasminogen activator according to current guidelines. Subsequent endovascular treatment was indicated, and written informed consent to conduct MT was obtained from the patient’s family. The endovascular procedure was performed with a transfemoral approach under conscious sedation. Cerebral angiography revealed occlusion of the left ACA (A4) (Fig. 2a). The location of the occlusion was ascertained following the segmentation of the ACA as described by Fischer [8]. A 9-Fr balloon guiding catheter (Optimo; Tokai Medical Products Inc., Kasugai, Japan) was advanced into the left internal carotid artery. A 2.3-Fr microcatheter was navigated over a microguidewire distal to the occlusion site and successful reperfusion (Thrombolysis in Cerebral Infarction [TICI] grade 3) was achieved on the first attempt using a stent retriever (Trevo 3 × 20 mm; Stryker Neurovascular, Kalamazoo, MI, USA) which was fully deployed and retrieved (Fig. 2b, c); 16 and 221 min elapsed from puncture to reperfusion and from onset to reperfusion (Fig. 2d), respectively. No procedure-related complications occurred. On the day following the procedure, the patient’s right hemiparesis receded, and her NIHSS score decreased to 2. Magnetic resonance imaging performed on the day following admission revealed infarcts in the left ACA territory and a small infarct in the left MCA territory (Fig. 3). The patient’s recovery progressed well, and she was discharged 13 days after admission with a modified Rankin Scale (mRS) score of 1. Her 90-day mRS score was 0.

Fig. 2.

a Cerebral angiogram reveals left anterior cerebral artery occlusion (A4). Arrow indicates occlusion site. b After positioning, a microcatheter contrast injection was performed to ensure intravascular positioning distally to the clot. Arrow indicates the tip of a microcatheter. c The stent retriever was fully deployed. d Immediately after mechanical thrombectomy, the occluded A4 was completely reperfused.

Fig. 2.

a Cerebral angiogram reveals left anterior cerebral artery occlusion (A4). Arrow indicates occlusion site. b After positioning, a microcatheter contrast injection was performed to ensure intravascular positioning distally to the clot. Arrow indicates the tip of a microcatheter. c The stent retriever was fully deployed. d Immediately after mechanical thrombectomy, the occluded A4 was completely reperfused.

Close modal
Fig. 3.

Postinterventional magnetic resonance imaging shows infarcts in the left anterior cerebral artery territory and a small infarct in the left middle cerebral artery territory (arrow).

Fig. 3.

Postinterventional magnetic resonance imaging shows infarcts in the left anterior cerebral artery territory and a small infarct in the left middle cerebral artery territory (arrow).

Close modal

The natural history of more distal occlusions has more favorable presentations and outcomes compared with large vessel occlusions owing to smaller infarct volumes. ACA occlusions account for 1.1–2.3% of all ischemic strokes [9-12] and tend to have a relatively favorable prognosis [13]. While prior research has demonstrated that distal occlusions of arteries may lead to significant neurological deficits and have highly pleomorphic clinical presentations [1-3], data on the natural history of the distal artery occlusions and the efficacy in treating the condition with MT are limited. Grossberg et al. [5] reported that ACA occlusions may cause hemiparesis, motor neglect, apraxia, abulia, aphasia, and mutism due to the involvement of the supplementary motor area, corpus callosum, anterior diencephalon, and deep neural structures. As our patient exhibited moderate neurological disability (NIHSS score of 11), we decided to perform MT. The clinical severity of her condition was greater than that typical of distal ACA occlusions. A lack of collateral flow and the simultaneous occlusion of left MCA branches as evinced by the infarct in the left MCA territory revealed by postinterventional magnetic resonance imaging may account for the elevated clinical severity. However, while imaging revealed no occlusion of the left MCA, occluded left MCA branches may have already been reperfused by the time of diagnostic imaging.

Most previous reports have used a stent retriever during MT, particularly in cases of more distal ACA occlusions [1-3, 14]. In treating the occlusion of distal, small-caliber vessels such as the ACA, navigating a microcatheter and deploying/retrieving the stent retriever can be challenging; however, no procedural complications were observed during the clinical course of our case. Pfaff et al. [14] reported one case of dissection (3.3%), while other studies reported no procedural complications including our previous work [1, 3, 7]. With the introduction of a 2.3-Fr microcatheter, the stent was safely navigated in our case. Thus, the risk of procedural complications during the treatment of distal ACA with MT does not seem higher than that during the treatment of MCA with MT [14] because the ACA runs relatively straight. The introduction of a smaller microcatheter is also considered to be one of the factors that allows safe performance of MT for distal vessel occlusions.

Our previous investigation with MT associated occluded ACA with a high recanalization rate and risk of futility [3]. Five patients with primary ACA occlusion had multiple occlusions in contralateral ACA or ipsilateral MCA. There was no case of solitary ACA occlusion. This case report demonstrates that solitary ACA occlusion responds well to MT. However, the treatment of distal artery occlusions with MT requires careful evaluation of the risks and benefits of conducting the procedure.

Primary ACA occlusion is rare and may cause significant neurological deficits. We treated a 76-year-old female who developed left A4 occlusion. She presented with a sudden onset of right hemiparesis. Neurological examination revealed her NIHSS score to be 11. We performed MT to treat the occlusion, which was successfully reperfused (TICI grade 3) 16 min after the puncture. The patient’s condition improved, and she was discharged without neurological deficit (mRS score of 1). This report may be used as a reference for the neurointerventional treatment of distal vessel occlusions.

Informed consent was obtained from all individual participants of this study.

None of the authors or co-authors have any conflict of interest to declare.

1.
Kurre
W
,
Vorlaender
K
,
Aguilar-Pérez
M
,
Schmid
E
,
Bäzner
H
,
Henkes
H
.
Frequency and relevance of anterior cerebral artery embolism caused by mechanical thrombectomy of middle cerebral artery occlusion
.
AJNR Am J Neuroradiol
.
2013
Aug
;
34
(
8
):
1606
11
.
[PubMed]
0195-6108
2.
King
S
,
Khatri
P
,
Carrozella
J
,
Spilker
J
,
Broderick
J
,
Hill
M
, et al;
IMS & IIMS II Investigators
.
Anterior cerebral artery emboli in combined intravenous and intra-arterial rtPA treatment of acute ischemic stroke in the IMS I and II trials
.
AJNR Am J Neuroradiol
.
2007
Nov-Dec
;
28
(
10
):
1890
4
.
[PubMed]
0195-6108
3.
Uno
J
,
Kameda
K
,
Otsuji
R
,
Ren
N
,
Nagaoka
S
,
Kazushi
M
, et al
Mechanical Thrombectomy for Acute Anterior Cerebral Artery Occlusion
.
World Neurosurg
.
2018
Dec
;
120
:
e957
61
.
[PubMed]
1878-8750
4.
Saber
H
,
Narayanan
S
,
Palla
M
,
Saver
JL
,
Nogueira
RG
,
Yoo
AJ
, et al
Mechanical thrombectomy for acute ischemic stroke with occlusion of the M2 segment of the middle cerebral artery: a meta-analysis
.
J Neurointerv Surg
.
2018
Jul
;
10
(
7
):
620
4
.
[PubMed]
1759-8478
5.
Grossberg
JA
,
Rebello
LC
,
Haussen
DC
,
Bouslama
M
,
Bowen
M
,
Barreira
CM
, et al
Beyond Large Vessel Occlusion Strokes: Distal Occlusion Thrombectomy
.
Stroke
.
2018
Jul
;
49
(
7
):
1662
8
.
[PubMed]
0039-2499
6.
Sarraj
A
,
Sangha
N
,
Hussain
MS
,
Wisco
D
,
Vora
N
,
Elijovich
L
, et al
Endovascular Therapy for Acute Ischemic Stroke With Occlusion of the Middle Cerebral Artery M2 Segment
.
JAMA Neurol
.
2016
Nov
;
73
(
11
):
1291
6
.
[PubMed]
2168-6149
7.
Chung
GH
,
Kwak
HS
,
Park
JS
,
Lee
JM
:
Manual aspiration thrombectomy with a Penumbra catheter for acute anterior cerebral artery occlusion.
Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences
2017
;23:416-421.
8.
Fischer
E
.
Die Lageabweichungen der vorderen Hirnarterie im Gefäßbild
.
Zentralbl Neurochir
.
1938
;
3
:
300
12
.0044-4251
9.
Moulin
T
,
Tatu
L
,
Vuillier
F
,
Berger
E
,
Chavot
D
,
Rumbach
L
.
Role of a stroke data bank in evaluating cerebral infarction subtypes: patterns and outcome of 1,776 consecutive patients from the Besançon stroke registry
.
Cerebrovasc Dis
.
2000
Jul-Aug
;
10
(
4
):
261
71
.
[PubMed]
1015-9770
10.
Kumral
E
,
Bayulkem
G
,
Evyapan
D
,
Yunten
N
.
Spectrum of anterior cerebral artery territory infarction: clinical and MRI findings
.
Eur J Neurol
.
2002
Nov
;
9
(
6
):
615
24
.
[PubMed]
1351-5101
11.
Vemmos
KN
,
Bots
ML
,
Tsibouris
PK
,
Zis
VP
,
Grobbee
DE
,
Stranjalis
GS
, et al
Stroke incidence and case fatality in southern Greece: the Arcadia stroke registry
.
Stroke
.
1999
Feb
;
30
(
2
):
363
70
.
[PubMed]
0039-2499
12.
Ghandehari
K
,
Izadi
Z
,
Khorasan Stroke
R
;
Khorasan Stroke Registry
.
The Khorasan Stroke Registry: results of a five-year hospital-based study
.
Cerebrovasc Dis
.
2007
;
23
(
2-3
):
132
9
.
[PubMed]
1015-9770
13.
Arboix
A
,
García-Eroles
L
,
Sellarés
N
,
Raga
A
,
Oliveres
M
,
Massons
J
.
Infarction in the territory of the anterior cerebral artery: clinical study of 51 patients
.
BMC Neurol
.
2009
Jul
;
9
(
1
):
30
.
[PubMed]
1471-2377
14.
Pfaff
J
,
Herweh
C
,
Pham
M
,
Schieber
S
,
Ringleb
PA
,
Bendszus
M
, et al
Mechanical Thrombectomy of Distal Occlusions in the Anterior Cerebral Artery: Recanalization Rates, Periprocedural Complications, and Clinical Outcome
.
AJNR Am J Neuroradiol
.
2016
Apr
;
37
(
4
):
673
8
.
[PubMed]
0195-6108
Open Access License / Drug Dosage / Disclaimer
This article is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC). Usage and distribution for commercial purposes requires written permission. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.